StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
MCI$17.81-1.27%
Fair $17.81+0.0%

MCI

Barings Corporate Investors

Financial Services / Asset ManagementNYSE

$17.81

-0.23 (-1.27%)

Fairly Valued+0.0%Fair Value $17.81Fund rank 35/100 · Data gapFallback financials|
SA 38/D
F-Score: 2/9
Declining Revenue

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 37.0/100

Data gap 35/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 68/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

38/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified. Revenue has declined for 2 consecutive years
Thesis & Journal · MCILocal privado en este navegador · Barings Corporate Investors
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$366M

P/E

13.0x

↑

EV/EBITDA

N/A

•

ROE

8.2%

↑

Gross Margin

N/A

•

Debt/Equity

0.22

↓
52-Week Range$18
$17$23

TradingView lightweight chart

MCI price, volumen y niveles de valoración

Último $17.81Periodo +69.1%
Fair value: $17.81

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+23.0%

FCF CAGR

+68.0%

FCF margin

61.5%

FCF / Net income

0.66x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $30.2M · net income $28.1M · FCF $18.6M

2022-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

93.0%+5.0% pts

FCF margin

61.5%+37.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$30.2M$30.2M$37.9M$39.2M$16.2M
Net Income$28.1M$28.1M$35.6M$37.0M$14.3M
EPS——1.751.820.71
Net Margin93.0%93.0%93.8%94.4%88.0%
Balance Sheet
Debt/Equity0.220.220.130.120.14
Current Ratio2.522.52———
Cash Flow
Free Cash Flow$18.6M$18.6M$28.1M$32.0M$3.9M
Returns
ROE8.2%8.2%10.4%10.9%4.3%
Valuation
P/E13.0013.0011.479.7319.59
P/B1.071.071.191.060.84
Growth & Yield
Revenue Growth-20.4%-20.4%-3.1%141.5%—
EPS Growth——-3.8%156.3%—
Dividend Yield9.0%9.0%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -5.6%

Total return

-5.6%

Start / end P/E

n/dx → n/dx

EPS bridge

1.75 → n/d

Residual

-14.6%

EPS growthn/d
Multiple reratingn/d
Dividend+9.0%
Residual / FX / buybacks / cross-term-14.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.